EyePoint Pharmaceuticals Inc (EYPT)

Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell

$5.86

Buy

$6.20

arrow-up$0.41 (+7.17%)

EyePoint Pharmaceuticals Inc, formerly pSivida Corp develops tiny, sustained-release, drug delivery products designed to deliver drugs at a controlled and steady rate for months or years.
Prices updated at 17 May 2025, 00:59 EDT
| Prices minimum 15 mins delay
|
Prices in USD
NASDAQ
arrow-up0.52%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Biotechnology
Chairman
Dr. Goran A. Ando, M.D.
CEO
Dr. Jay S. Duker, M.D.
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
144
Head office
480 Pleasant Street
Watertown
United States
02472
mobile
+1 617 926-5000
letter
-
computer
Company website

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Dr. Reginald Sanders, M.D.
Director
-----
Mr. Fred Hassan
Director
0.02m--0.41m-
Ms. Nancy S. Lurker
Executive Vice Chairman of the Board
0.04m--2.06m-
Ms. Wendy F. DiCicco
Independent Director
0.08m--0.48m-
Mr. George O. Elston
Executive Vice President, Chief Financial Officer and Principal Accounting Officer
0.51m--3.20m-
Dr. John B. Landis, PhD
Director
0.46m--1.38m-
Ms. Karen Zaderej
Independent Director
0.06m--0.46m-
Dr. Jay S. Duker, M.D.
Director, President and Chief Executive Officer
0.67m--5.95m-
Dr. Goran A. Ando, M.D.
Chairman of the Board
0.10m--0.48m-
Mr. Stuart M. Duty
Independent Director
0.06m--0.46m-
Dr. Ramiro Ribeiro, M.D.,PhD
Chief Medical Officer
0.40m0.06m-3.53m-

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
Cormorant Asset Management, LP8,325,000-228676537.87141430 Apr 202512.20
Cormorant Asset Management, LLC8,325,0003.40615--30 Apr 202512.10
Suvretta Capital Management, LLC6,804,0911.36845210000.30959330 Apr 20259.89
Adage Capital Partners Gp LLC5,750,0000.07491195858051.65821830 Apr 20258.36
BlackRock Inc5,722,0450.000654406708.3438530 Apr 20258.32

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
03 Sep 2024-Mr. Fred Hassan--60,000--
21 Aug 2024-Dr. Goran A. Ando, M.D.7.9539,75013,150--
20 Aug 2024-Ms. Wendy F. DiCicco7.7919,9979,967--
19 Aug 2024-Ms. Karen Zaderej7.9899,75016,500--
16 Aug 2024-Ms. Nancy S. Lurker7.8825,00397,635--
26 Jul 2024-Ms. Nancy S. Lurker--95,000--
26 Jul 2024-Ms. Nancy S. Lurker--182,535--
26 Jul 2024-Ms. Nancy S. Lurker--31,165--
26 Jul 2024-Ms. Nancy S. Lurker-----
26 Jul 2024-Ms. Nancy S. Lurker--74,800--
26 Jul 2024-Ms. Nancy S. Lurker--16,666--
26 Jul 2024-Ms. Nancy S. Lurker--50,000--
26 Jul 2024-Ms. Nancy S. Lurker--169,050--
26 Jul 2024-Ms. Nancy S. Lurker--281,750--
26 Jul 2024-Ms. Nancy S. Lurker--145,000--
12 Jul 2024-Dr. David R. Guyer,M.D.3.2621,27213,475--
12 Jul 2024-Dr. David R. Guyer,M.D.--6,525--
12 Jul 2024-Dr. David R. Guyer,M.D.--3,250--
12 Jul 2024-Dr. David R. Guyer,M.D.10.06116,9951,850--
12 Jul 2024-Dr. David R. Guyer,M.D.3.5011,3756,950--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.